US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Monkeypox Concept

2,052.04

-1.1470-0.06%

Number of Gainers:2

Number of Losers:7

Number of Flat:2

PE:- -

High:2,053.35

Open:2,037.05

Low:2,021.05

Close:2,053.18

Volume:3.66M

Turnover:146.06M

Market Cap:227.07B

Float Cap:226.36B

Loading ...

Aethlon Medical Completes Warrant Exercises, Clarifying Capitalization

Aethlon Medical Says All Pre-Funded Warrants are Exercised

Tonix CEO Seth Lederman Acquires 2,000 Common Shares for $27,580

Emergent BioSolutions - Awarded Standing Offer to Supply Narcan Nasal Spray in Canada

THOMSON REUTERS

Emergent BioSolutions - Standing Offer Effective Oct 1, 2026-Sept 30, 2029 with Two-Year Extension Option

THOMSON REUTERS

Emergent BioSolutions Reinforces Commitment to Opioid Overdose Education and Preparedness on International Overdose Awareness Day

Gilead (GILD) Stock Stays Cheap After A 143% Five Year Run

Simply Wall St.

Gilead Sciences Inc. Stock Underperforms Friday When Compared to Competitors

GeoVax Faces NASDAQ Delisting After Shares Stay Below $1 Bid Price Threshold

GeoVax Labs Secures Immediate Exercise of 5,697,628 Stock Warrants at USD 0.64

Viatris Drops in Late Session Volume Surge, Last Off 3.4%

THOMSON REUTERS

Gilead Breaks Ground on Foster City Biologics Facility in $32 Billion US Investment Push

Gilead Sciences Director Anthony Welters Disposes of USD 2.64 Million in Common Shares

Gilead’s Bixlenvo approved by FDA for virologically suppressed adults with HIV

US FDA Approves Gilead's Once-Daily Combination Pill for HIV Treatment

U.S. FDA Approves Gilead’s Bixlenvo™, a New Once-Daily Single Tablet Option for Virologically Suppressed Adults with Hiv, Including Those on Complex Regimens

THOMSON REUTERS

Inovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared to Competitors

Moderna Inc. Stock Slips 4.6%, Underperforms Peers

Shield Therapeutics to Assume Full Commercial Control of ACCRUFeR in US

Virax Biolabs Adjourns Shareholder Meeting After Quorum Fails to Show

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/BK4583/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4583","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4583\",,,,,undefined,":{"symbol":"BK4583","market":"US","secType":"PLATE","nameCN":"Monkeypox Concept","latestPrice":2052.0361,"timestamp":1788187915204,"preClose":2053.183,"halted":0,"volume":3662898,"delay":0,"changeRate":-0.000559,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":-1.146973,"latestTime":"08-31 10:51:55 EDT","open":2037.0466,"high":2053.3472,"low":2021.0533,"amount":146059368.089793,"amplitude":0.015729,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788206400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":6.7497,"peRate":-76.582617,"turnoverRate":0.001357,"increases":2,"decrements":8,"flats":0,"marketCap":227067447542,"floatMarketCap":226362849603.5},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4583\",,,,,undefined,":{"symbol":"BK4583","high":2053.3472,"amplitude":0.015729,"preClose":2053.183,"low":2021.0533,"pbRate":"6.7497","latestPrice":2052.0361,"volume":3663968,"delay":0,"open":2037.0466,"prevYearClose":1682.3505,"prevWeekClose":2053.183,"prevMonthClose":1882.546,"prevQuarterClose":1802.0435,"fiveDayClose":2067.7861,"twentyDayClose":1892.7968,"sixtyDayClose":1820.2448,"secType":"PLATE","market":"US","turnoverRate":0.001357,"peRate":-76.582617,"marketCap":227067440431,"floatMarketCap":226362842533.5,"timestamp":1788187919526,"nameCN":"Monkeypox Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4583\",,,,undefined,":{"bkCode":"BK4583","up":2,"down":7,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4583\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2663515009","title":"Aethlon Medical Completes Warrant Exercises, Clarifying Capitalization","url":"https://stock-news.laohu8.com/highlight/detail?id=2663515009","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663515009?lang=en_us&edition=fundamental","pubTime":"2026-08-31 21:51","pubTimestamp":1788184315,"startTime":"0","endTime":"0","summary":"An announcement from Aethlon Medical ( ($AEMD) ) is now available. Aethlon Medical, Inc. reported that, following recent exercises of certain pre-f...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aethlon-medical-completes-warrant-exercises-clarifying-capitalization?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aethlon-medical-completes-warrant-exercises-clarifying-capitalization?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4583","AEMD","BK4082","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663057430","title":"Aethlon Medical Says All Pre-Funded Warrants are Exercised","url":"https://stock-news.laohu8.com/highlight/detail?id=2663057430","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663057430?lang=en_us&edition=fundamental","pubTime":"2026-08-31 21:15","pubTimestamp":1788182150,"startTime":"0","endTime":"0","summary":"Aethlon Medical says all pre-funded warrants are exercisedAethlon Medical reported all previously outstanding pre-funded warrants were exercised following recent warrant exercises.Common shares outsta","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDLc5SWhH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AEMD","BK4082","BK4583","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663500860","title":"Tonix CEO Seth Lederman Acquires 2,000 Common Shares for $27,580","url":"https://stock-news.laohu8.com/highlight/detail?id=2663500860","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663500860?lang=en_us&edition=fundamental","pubTime":"2026-08-31 20:01","pubTimestamp":1788177663,"startTime":"0","endTime":"0","summary":"Tonix CEO Seth Lederman acquires 2,000 common shares for $27,580Tonix Pharmaceuticals CEO Seth Lederman reported buying 2,000 common shares at $13.79 through an IRA account.IRA-held stake rose to 11,0","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL2KqGnx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Tonix CEO Seth Lederman Acquires 2,000 Common Shares for $27,580","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","TNXP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663600881","title":"Emergent BioSolutions - Awarded Standing Offer to Supply Narcan Nasal Spray in Canada","url":"https://stock-news.laohu8.com/highlight/detail?id=2663600881","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663600881?lang=en_us&edition=fundamental","pubTime":"2026-08-31 19:55","pubTimestamp":1788177322,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S0BR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","EBS","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663008819","title":"Emergent BioSolutions - Standing Offer Effective Oct 1, 2026-Sept 30, 2029 with Two-Year Extension Option","url":"https://stock-news.laohu8.com/highlight/detail?id=2663008819","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663008819?lang=en_us&edition=fundamental","pubTime":"2026-08-31 19:55","pubTimestamp":1788177322,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S0BR:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4583","EBS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663008437","title":"Emergent BioSolutions Reinforces Commitment to Opioid Overdose Education and Preparedness on International Overdose Awareness Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2663008437","media":"GlobeNewswire","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663008437?lang=en_us&edition=fundamental","pubTime":"2026-08-31 19:54","pubTimestamp":1788177240,"startTime":"0","endTime":"0","summary":"Ready to Rescue campaign returns to U.S. college campuses with Release Recovery Founder and CEO Zac ClarkPartnership with professional baseball player Davis Schneider seeks to raise awareness of opioi","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/31/3353232/33240/en/emergent-biosolutions-reinforces-commitment-to-opioid-overdose-education-and-preparedness-on-international-overdose-awareness-day.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4583","EBS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663043488","title":"Gilead (GILD) Stock Stays Cheap After A 143% Five Year Run","url":"https://stock-news.laohu8.com/highlight/detail?id=2663043488","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663043488?lang=en_us&edition=fundamental","pubTime":"2026-08-30 07:30","pubTimestamp":1788046226,"startTime":"0","endTime":"0","summary":"Gilead Sciences stock has delivered very strong gains over the past few years, yet current valuation checks still suggest the shares screen as inexpensive on several metrics. The question for investors is how that strong track record and the latest product approvals align with a profile that continues to lean cheap.\n\nOver 5 years the stock has returned about 143%, which puts recent moves in the context of a long, powerful run that investors now need to judge against today’s pricing.\nThe...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/29002-main-header/1756252861953","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/29002-main-header/1756252861953"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/gilead-gild-stock-stays-cheap-after-a-143-five-year-run","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/gilead-gild-stock-stays-cheap-after-a-143-five-year-run","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2468319806.SGD","LU0289739699.SGD","LU1839511570.USD","IBB","BK4583","LU0114720955.EUR","TBXU","LU1571399168.USD","LU1934455194.USD","LU1430594728.SGD","BMED","SG9999015978.USD","LU0965509010.AUD","BIB","LU1066051498.USD","LU2089984988.USD","LU0882574055.USD","BK4532","LU1934455863.HKD","LU1934455277.USD","IE00B19Z3B42.SGD","BBH","BK4566","LU0234570918.USD","BK4585","LU2112291526.USD","LU0058720904.USD","IBBQ","BK4568","LU1061106388.HKD","MEDI","BK4139","IE00BKVL7J92.USD","LU0965509283.SGD","LU1023059063.AUD","LU2324357040.USD","BK4588","BK4550","LU0823416689.USD","GILD","LU0965508806.USD","LU1066053197.SGD","IE00B3T34201.USD","LU1585245621.USD","IE00BZ1G4Q59.USD","LU0109394709.USD","LU0122379950.USD","BK4578","TMED","SG9999015945.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663701587","title":"Gilead Sciences Inc. Stock Underperforms Friday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2663701587","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663701587?lang=en_us&edition=fundamental","pubTime":"2026-08-29 04:35","pubTimestamp":1787949300,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Underperforms Friday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  slid 2.14% to $145.68 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 0.25% to 7,711.76 and Dow Jones Industrial Average  falling 0.02% to 53,559.99.Gilead Sciences Inc. closed 7.38% short of its 52-week high of $157.29, which the company achieved on February 11th.The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson  rose 0.85% to $268.04, Pfizer Inc.  fell 0.21% to $27.96, and Abbott Laboratories  rose 0.79% to $112.47.Trading volume  remained 3.2 million below its 50-day average volume of 7.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 28, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3T34201.USD","LU0965509101.SGD","LU1585245621.USD","LU0965509283.SGD","BK4532","TBXU","MEDI","LU0882574055.USD","IBBQ","LU0058720904.USD","LU0861579265.USD","IE00BKVL7J92.USD","IE00B19Z3581.USD","BK4566","LU1066051498.USD","LU1934455863.HKD","LU0122379950.USD","LU0889565916.HKD","LU1057294990.SGD","LU2112291526.USD","SG9999015952.SGD","BK4578","SG9999015986.USD","LU0289739699.SGD","IE0002270589.USD","LU1839511570.USD","LU1037948897.HKD","IE00BZ1G4Q59.USD","LU1061106388.HKD","TMED","LU1037948541.HKD","SG9999015945.SGD","LU0859254822.USD","IE00BSNM7G36.USD","BBH","LU1934455194.USD","BK4550","LU2087621335.USD","LU1674673428.USD","LU2357627491.SGD","IBB","LU1066053197.SGD","BMED","LU1674673691.USD","LU0109394709.USD","IE00B7SZLL34.SGD","BK4585","GILD","LU0320765992.SGD","BK4139","BK4568","LU2089984988.USD","LU2324357040.USD","LU0234570918.USD","LU0965509010.AUD","LU1023059063.AUD","LU0114720955.EUR","BK4583","IE00B19Z3B42.SGD","LU1934455277.USD","LU1571399168.USD","LU1778281490.HKD","SG9999015978.USD","LU1430594728.SGD","LU2468319806.SGD","LU0965508806.USD","LU0823416689.USD","BK4588","BIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663132960","title":"GeoVax Faces NASDAQ Delisting After Shares Stay Below $1 Bid Price Threshold","url":"https://stock-news.laohu8.com/highlight/detail?id=2663132960","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663132960?lang=en_us&edition=fundamental","pubTime":"2026-08-29 04:18","pubTimestamp":1787948305,"startTime":"0","endTime":"0","summary":"GeoVax faces Nasdaq delisting after shares stay below $1 bid price thresholdGeoVax received a Nasdaq staff determination to delist its common stock for failing the $1 minimum bid price rule.Shares tra","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL8Q0Gfd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","GOVX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663013496","title":"GeoVax Labs Secures Immediate Exercise of 5,697,628 Stock Warrants at USD 0.64","url":"https://stock-news.laohu8.com/highlight/detail?id=2663013496","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663013496?lang=en_us&edition=fundamental","pubTime":"2026-08-29 04:10","pubTimestamp":1787947827,"startTime":"0","endTime":"0","summary":"GeoVax Labs secures immediate exercise of 5,697,628 stock warrants at USD 0.64GeoVax entered a warrant inducement deal for immediate exercise of existing warrants for 5,697,628 shares at USD 0.64.Gros","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL3WgVxl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GOVX","BK4583","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663013606","title":"Viatris Drops in Late Session Volume Surge, Last Off 3.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663013606","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663013606?lang=en_us&edition=fundamental","pubTime":"2026-08-29 03:56","pubTimestamp":1787946970,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL6N44P11Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VTRS","LU2087621335.USD","BK4585","BK4007","BK4583","BK4588","LU1839511570.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662762030","title":"Gilead Breaks Ground on Foster City Biologics Facility in $32 Billion US Investment Push","url":"https://stock-news.laohu8.com/highlight/detail?id=2662762030","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662762030?lang=en_us&edition=fundamental","pubTime":"2026-08-28 10:17","pubTimestamp":1787883449,"startTime":"0","endTime":"0","summary":"Gilead breaks ground on Foster City biologics facility in $32 billion US investment pushGilead broke ground on its Chess biologics facility at its Foster City, California headquarters as part of a pla","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL98vB5b:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BMED","BK4578","LU0965509101.SGD","TBXU","LU1037948541.HKD","BBH","LU0109394709.USD","LU0889565916.HKD","SG9999015952.SGD","LU1061106388.HKD","LU0859254822.USD","BK4568","LU1066053197.SGD","LU1037948897.HKD","IBB","IE00BKVL7J92.USD","LU1430594728.SGD","IE00BSNM7G36.USD","IBBQ","BIB","BK4583","BK4588","IE0002270589.USD","LU0320765992.SGD","LU2087621335.USD","TMED","LU1934455194.USD","LU2357627491.SGD","LU0965509283.SGD","LU2468319806.SGD","LU0234570918.USD","LU0823416689.USD","LU0289739699.SGD","MEDI","LU1934455863.HKD","IE00B7SZLL34.SGD","LU1674673691.USD","LU0965509010.AUD","LU1674673428.USD","LU0058720904.USD","GILD","LU2112291526.USD","LU0861579265.USD","LU0965508806.USD","LU1057294990.SGD","IE00B19Z3581.USD","LU1066051498.USD","LU1571399168.USD","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662394370","title":"Gilead Sciences Director Anthony Welters Disposes of USD 2.64 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2662394370","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662394370?lang=en_us&edition=fundamental","pubTime":"2026-08-28 06:45","pubTimestamp":1787870729,"startTime":"0","endTime":"0","summary":"Gilead Sciences director Anthony Welters disposes of USD 2.64 million in common sharesGilead director Anthony Welters exercised stock options for 18,000 shares on Aug. 26, 2026 at prices of USD 60.67 ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL29Bbzm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Gilead Sciences Director Anthony Welters Disposes of USD 2.64 Million in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","LU2324357040.USD","LU1674673428.USD","LU1023059063.AUD","SG9999015986.USD","LU0058720904.USD","IE00B19Z3581.USD","LU0122379950.USD","LU2087621335.USD","LU1585245621.USD","IBBQ","LU0861579265.USD","MEDI","IE00BSNM7G36.USD","LU1430594728.SGD","BK4585","BK4583","BK4588","LU1934455863.HKD","LU0289739699.SGD","LU1057294990.SGD","LU1066051498.USD","LU0889565916.HKD","LU1037948897.HKD","BK4578","LU0823416689.USD","BMED","IE00B7SZLL34.SGD","BK4568","BK4532","TBXU","LU1061106388.HKD","BBH","LU0965508806.USD","BK4139","IBB","LU0965509010.AUD","GILD","IE00B19Z3B42.SGD","LU0965509101.SGD","TMED","LU1839511570.USD","LU2112291526.USD","BIB","LU0109394709.USD","IE00B3T34201.USD","LU1571399168.USD","IE0002270589.USD","LU0859254822.USD","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662036059","title":"Gilead’s Bixlenvo approved by FDA for virologically suppressed adults with HIV","url":"https://stock-news.laohu8.com/highlight/detail?id=2662036059","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662036059?lang=en_us&edition=fundamental","pubTime":"2026-08-28 05:55","pubTimestamp":1787867719,"startTime":"0","endTime":"0","summary":"Gilead (GILD) Sciences announced that the FDA approved Bixlenvo – bictegravir 75 mg/lenacapavir 50 mg -, the smallest once-daily single tablet regi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gileads-bixlenvo-approved-by-fda-for-virologically-suppressed-adults-with-hiv-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gileads-bixlenvo-approved-by-fda-for-virologically-suppressed-adults-with-hiv-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BSNM7G36.USD","LABU","LU0965509101.SGD","LU1674673428.USD","BK4532","LU0823416689.USD","IBB","LU1066053197.SGD","LU1934455194.USD","LU2357627491.SGD","BBH","BK4568","SG9999015986.USD","LU0861579265.USD","LU1066051498.USD","BK4588","LU0234570918.USD","LU0889565916.HKD","LU1037948897.HKD","BIB","IE00BZ1G4Q59.USD","LU1057294990.SGD","LU0859254822.USD","IE00B19Z3581.USD","BK4566","SG9999015952.SGD","TMED","LU0109394709.USD","LU1839511570.USD","IBBQ","GILD","LU0058720904.USD","LU1023059063.AUD","LU1061106388.HKD","MEDI","IE00B19Z3B42.SGD","LU1585245621.USD","BK4585","BMED","LU1674673691.USD","BK4583","LU2087621335.USD","SG9999015945.SGD","LU2324357040.USD","LU0965509283.SGD","TBXU","LU1571399168.USD","LU0122379950.USD","LU1934455863.HKD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662036301","title":"US FDA Approves Gilead's Once-Daily Combination Pill for HIV Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2662036301","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662036301?lang=en_us&edition=fundamental","pubTime":"2026-08-28 05:50","pubTimestamp":1787867441,"startTime":"0","endTime":"0","summary":"US FDA approves Gilead's once-daily combination pill for HIV treatmentAug 27 -The U.S. Food and Drug Administration has approved Gilead Sciences'GILD.Oonce daily oral combination pill for treatment of adults whose HIV has already been reduced to very low levels, the company said on Thursday.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL4N44O24M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","LU0965509010.AUD","BK4139","LU1585245621.USD","LU0122379950.USD","LU1061106388.HKD","LU1934455863.HKD","LU0114720955.EUR","LU1934455277.USD","IBB","IE00B19Z3B42.SGD","LU1066051498.USD","SG9999015945.SGD","LU2357627491.SGD","LU0889565916.HKD","BK4578","IE00B3T34201.USD","LU1674673428.USD","BK4583","IE00B7SZLL34.SGD","LU0965509101.SGD","LU0861579265.USD","IE0002270589.USD","LU2324357040.USD","TMED","GILD","LU0882574055.USD","BMED","LU0234570918.USD","LU0289739699.SGD","LU0320765992.SGD","LU1037948541.HKD","LU1037948897.HKD","LU2468319806.SGD","LU1778281490.HKD","IE00B19Z3581.USD","LU1057294990.SGD","BK4585","IBBQ","BBH","LU1839511570.USD","SG9999015952.SGD","LU0965508806.USD","TBXU","MEDI","BIB","LU1023059063.AUD","BK4566","IE00BZ1G4Q59.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662036807","title":"U.S. FDA Approves Gilead’s Bixlenvo™, a New Once-Daily Single Tablet Option for Virologically Suppressed Adults with Hiv, Including Those on Complex Regimens","url":"https://stock-news.laohu8.com/highlight/detail?id=2662036807","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662036807?lang=en_us&edition=fundamental","pubTime":"2026-08-28 05:47","pubTimestamp":1787867220,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nTUA7M9KZ1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4568","BK4585","SG9999015978.USD","LU2089984988.USD","MEDI","BBH","IE00B19Z3B42.SGD","LU0320765992.SGD","LU0965509283.SGD","IE00B7SZLL34.SGD","LU1571399168.USD","BK4550","BIB","LU2087621335.USD","LU0109394709.USD","LU2468319806.SGD","LU1066051498.USD","LU0234570918.USD","BK4532","TBXU","LU0823416689.USD","LU0861579265.USD","LU1934455194.USD","SG9999015945.SGD","IBBQ","BK4583","LU1066053197.SGD","BMED","LU0289739699.SGD","BK4566","TMED","LU0882574055.USD","GILD","IE00B3T34201.USD","LU1934455277.USD","LU0965509010.AUD","LU1057294990.SGD","IBB","BK4578","LU1839511570.USD","LU1061106388.HKD","LU1430594728.SGD","LU2112291526.USD","LU1037948897.HKD","LU1778281490.HKD","IE00BKVL7J92.USD","BK4588","IE00BZ1G4Q59.USD","LU0889565916.HKD","LU1934455863.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662035261","title":"Inovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2662035261","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662035261?lang=en_us&edition=fundamental","pubTime":"2026-08-28 05:25","pubTimestamp":1787865900,"startTime":"0","endTime":"0","summary":"DJ Inovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Inovio Pharmaceuticals Inc.  shed 3.08% to $1.26 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index  rising 1.57% to 26,541.35 and the Dow Jones Industrial Average  rising 0.20% to 53,569.44.The stock's fall snapped a three-day winning streak.Inovio Pharmaceuticals Inc. closed 57.70% below its 52-week high of $2.98, which the company reached on September 9th.The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson  fell 1.57% to $265.77, Statera Biopharma Inc.  remained unchanged, and Pfizer Inc.  fell 0.99% to $28.02.Trading volume  remained 1.4 million below its 50-day average volume of 3.7 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 27, 2026.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","BK4139","BK4568","INO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662033626","title":"Moderna Inc. Stock Slips 4.6%, Underperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2662033626","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662033626?lang=en_us&edition=fundamental","pubTime":"2026-08-28 04:34","pubTimestamp":1787862840,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. slid 4.6% to $142.77 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.6% to 26,541.35 and the Dow Jones Industrial Average rising 0.2% to 53,569.44.This was the stock's second consecutive day of losses.Moderna Inc. closed 19.2% short of its 52-week high of $176.66, which the company reached on August 19th.The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 1.6% to $265.77, Pfizer Inc. fell 1.0% to $28.02, and Gilead Sciences Inc. rose 0.52% to $148.86.Trading volume totaled 24.9 million, compared to the 50-day average of 16.4 million.Data source: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1571399168.USD","WDNA","LU0058720904.USD","IE00B7SZLL34.SGD","BMED","LU1934455277.USD","MEDI","LGHT","LU0965509283.SGD","LU2357627491.SGD","MRNA","BK4139","IE00BKVL7J92.USD","BK4534","LU1934455194.USD","BK4533","SG9999015945.SGD","LU0861579265.USD","LU1674673691.USD","BIB","BK4588","LU1037948541.HKD","IDNA","IBBQ","BK4550","BK4568","BBH","TBXU","LU0114720955.EUR","LU2468319806.SGD","LU0965508806.USD","LU0109394709.USD","MRNX","BK4583","GILD","LU1061106388.HKD","LU0965509010.AUD","LU1674673428.USD","LU1066053197.SGD","BK4551","MRNY","LU0889565916.HKD","GNOM","TMED","IBB","LU2324357040.USD","LU0320765992.SGD","SG9999015952.SGD","SG9999015986.USD","IE00B19Z3581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662081862","title":"Shield Therapeutics to Assume Full Commercial Control of ACCRUFeR in US","url":"https://stock-news.laohu8.com/highlight/detail?id=2662081862","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662081862?lang=en_us&edition=fundamental","pubTime":"2026-08-27 23:36","pubTimestamp":1787845010,"startTime":"0","endTime":"0","summary":"Aug 27 (Reuters) - Shield Therapeutics PLC::*SHIELD THERAPEUTICS - TO ASSUME FULL COMMERCIAL CONTROL OF ACCRUFER IN US WITH CLOSING EXPECTED SEPT 30, 2026*SHIELD THERAPEUTICS PLC: HAS ENTERED INTO AGR","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nRSD99NKXz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","LU1839511570.USD","BK4588","BK4585","LU2087621335.USD","BK4007","VTRS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662744748","title":"Virax Biolabs Adjourns Shareholder Meeting After Quorum Fails to Show","url":"https://stock-news.laohu8.com/highlight/detail?id=2662744748","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662744748?lang=en_us&edition=fundamental","pubTime":"2026-08-27 04:33","pubTimestamp":1787776426,"startTime":"0","endTime":"0","summary":"Virax Biolabs adjourns shareholder meeting after quorum fails to showVirax Biolabs’ Aug. 14 shareholder meeting was delayed due to a lack of quorum, with 6.33% of eligible shares represented.The meeti","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL32cpwH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","BK4175","VRAX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":56,"code":"91000000","status":"200"}]}}